Radiation-induced eosinophils improve cytotoxic T lymphocyte recruitment and response to immunotherapy

被引:56
作者
Cheng, Jia-Nan [1 ,2 ]
Luo, Wen [1 ,3 ]
Sun, Chengdu [1 ,2 ]
Jin, Zheng [4 ]
Zeng, Xianghua [1 ,2 ]
Alexander, Peter B. [5 ]
Gong, Zhihua [1 ,2 ]
Xia, Xin [1 ,2 ]
Ding, Xiaofang [1 ,2 ]
Xu, Shouxia [1 ,2 ]
Zou, Ping [1 ,2 ]
Wan, Yisong Y. [6 ]
Jia, Qingzhu [1 ,2 ]
Li, Qi-Jing [5 ]
Zhu, Bo [1 ,2 ]
机构
[1] Chongqing Key Lab Immunotherapy, Chongqing 400037, Peoples R China
[2] Third Mil Med Univ, Xinqiao Hosp, Dept Oncol, Chongqing 400037, Peoples R China
[3] Third Mil Med Univ, Xinqiao Hosp, Dept Radiotherapy, Chongqing 400037, Peoples R China
[4] GloriousMed Clin Lab Shanghai Co Ltd, Shanghai, Peoples R China
[5] Duke Univ, Dept Immunol, Med Ctr, Durham, NC 27710 USA
[6] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
基金
中国国家自然科学基金;
关键词
Cytology; -; Radiotherapy; Radiation; Tumors; Diseases;
D O I
10.1126/sciadv.abc7609
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The efficacy of cancer immunotherapy is dictated by CD8(+) T cell infiltration and the nature of the tumor micro-environment (TME). By inflaming the TME to favor CD8(+) T cell immunity, radiation is now widely considered as a neoadjuvant for immunomodulation. Here, we observed that local irradiation enhances the infiltration of intratumoral eosinophils, and depletion of eosinophil dampens CD8(+) T cell infiltration and diminishes the anti-tumor effectiveness of radiation. Retrospectively, we identified a strong correlation between eosinophilia and survival benefit in radiation-treated cancer patients. Experimentally, we further show that radiation enhances the intra-tumoral infiltration of adoptive transferred T cells therapy, bolstering eosinophils by intravenous interleukin-5 administration promotes the efficacy of radiation-induced abscopal effect. Together, these results suggest that eosinophil mobilization can be considered as a mechanistically relevant biomarker for predicting the effectiveness of pre-immunotherapy radiation, as well as a new strategy to enhance T cell-mediated immunotherapy against cancers.
引用
收藏
页数:13
相关论文
共 58 条
[1]   Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Kurata, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
Carpeno, J. de Castro ;
Faivre-Finn, C. ;
Reck, M. ;
Vansteenkiste, J. ;
Spigel, D. R. ;
Wadsworth, C. ;
Melillo, G. ;
Taboada, M. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350
[2]   Immune checkpoint blockade in hematologic malignancies [J].
Armand, Philippe .
BLOOD, 2015, 125 (22) :3393-3400
[3]   Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review [J].
Austin Huy Nguyen ;
Detty, Shannon Q. ;
Agrawal, Devendra K. .
ANTICANCER RESEARCH, 2017, 37 (01) :1-7
[4]   IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade [J].
Ayers, Mark ;
Lunceford, Jared ;
Nebozhyn, Michael ;
Murphy, Erin ;
Loboda, Andrey ;
Kaufman, David R. ;
Albright, Andrew ;
Cheng, Jonathan D. ;
Kang, S. Peter ;
Shankaran, Veena ;
Piha-Paul, Sarina A. ;
Yearley, Jennifer ;
Seiwert, Tanguy Y. ;
Ribas, Antoni ;
McClanahan, Terrill K. .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (08) :2930-2940
[5]   HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins [J].
Bertheloot, Damien ;
Latz, Eicke .
CELLULAR & MOLECULAR IMMUNOLOGY, 2017, 14 (01) :43-64
[6]  
CALDENHOVEN E, 1994, J BIOL CHEM, V269, P21146
[7]   Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer [J].
Cao, ZA ;
Daniel, D ;
Hanahan, D .
BMC CANCER, 2002, 2 (1)
[8]   Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells [J].
Carretero, Rafael ;
Sektioglu, Ibrahim M. ;
Garbi, Natalio ;
Salgado, Oscar C. ;
Beckhove, Philipp ;
Haemmerling, Guenter J. .
NATURE IMMUNOLOGY, 2015, 16 (06) :609-+
[9]   In Vivo Expansion and Antitumor Activity of Coinfused CD28-and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia [J].
Cheng, Zhi ;
Wei, Runhong ;
Ma, Qiuling ;
Shi, Lin ;
He, Feng ;
Shi, Zixiao ;
Jin, Tao ;
Xie, Ronglin ;
Wei, Baofeng ;
Chen, Jing ;
Fang, Hongliang ;
Han, Xiaolu ;
Rohrs, Jennifer A. ;
Bryson, Paul ;
Liu, Yarong ;
Li, Qi-Jing ;
Zhu, Bo ;
Wang, Pin .
MOLECULAR THERAPY, 2018, 26 (04) :976-985
[10]   Standardizing CAR-T therapy: Getting it scaled up [J].
Dai, Xiaofeng ;
Mei, Yi ;
Cai, Dongyan ;
Han, Weidong .
BIOTECHNOLOGY ADVANCES, 2019, 37 (01) :239-245